May 20, 2020
Joan Garrett, PhD, assistant professor of pharmaceutical sciences at the University of Cincinnati's James L. Winkle College of Pharmacy, hopes to learn more about HER3 and its role in breast cancer development.
April 19, 2022
The University of Cincinnati James L. Winkle College of Pharmacy, UC Medical Center and Walgreens are launching CincyUp, a first-of-its-kind visiting Advanced Pharmacy Practice Experience (APPE) pilot program for underrepresented pharmacy students.
October 26, 2022
The University of Cincinnati's Kelly Dobos was featured in a Washington Post article about the recent recall of more than a dozen dry shampoos due to the possibility they contain “elevated levels” of benzene.
November 2, 2022
A collaborative research team at the University of Cincinnati has received a $3.5 million National Institutes of Health grant to examine how current HIV medications are affected by alcohol use alone or in combination with fentanyl.
November 15, 2022
The University of Cincinnati's Randall Wickett spoke with Cosmetics Design Asia about the importance of cosmetics industries being able to verify claims about their products and new technology that will allow the industry to do so.
April 29, 2022
The University of Cincinnati's Jill Boone was featured in a Local 12 story on the impact of staffing issues at local pharmacies.
July 11, 2022
Over decades of ups and downs, the hard work of University of Cincinnati alumnus John Drach paid off when the FDA approved a new drug he helped develop to treat cytomegalovirus.
August 10, 2022
University of Cincinnati researchers Jason Gardner and Matthew Robson are studying whether targeting an inflammation pathway that affects burns and traumatic brain injuries can be an effective treatment for both conditions.
July 28, 2022
Siblings Ally and Adam Klaserner are current students in the James L. Winkle College of Pharmacy, and their parents John and Lorrie are alumni of the UC pharmacy program.
March 22, 2023
Local 12 highlighted the University of Cincinnati's Bingfang Yan, who recently received a a $2.5 million National Institutes of Health grant to study how COVID-19 therapeutics can work together to create more effective and safe treatments for patients.